Icon

RAPIBLYK - (280MG)

LANDIOLOL HYDROCHLORIDE None
280MG
Less Than $1000 mn
None None
None None
None None
RAPIBLYK is a beta adrenergic blocker indicated for the short-term reduction of ventricular rate in adults with supraventricular tachycardia including atrial fibrillation and atrial flutter.
Yes
RAPIBLYK Patent 1
*** *********

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.